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The high consumption of metal-containing
products by industrial societies inevitably leads
to environmental pollution by heavy metals,
including nickel(II), chromium(VI), and
cobalt(II), at all stages of production, use, and
disposal. Human occupational exposure to
metals occurs primarily via inhalation and
ingestion of metal-containing dusts and is par-
ticularly high among stainless steel welders,
miners, and metallurgy workers. The environ-
mental exposure mostly results from burning
of fossil fuels. Accumulation of metals in the
human body can cause different diseases,
including cancer. There is sufﬁcient evidence
in humans for the carcinogenicity of Cr(VI)
and Ni(II) [International Agency for Research
on Cancer (IARC) 1990], which are not
known to be essential in humans, and limited
experimental animal data support Co(II) car-
cinogenicity [Bucher et al. 1999; National
Toxicology Program (NTP) 1998].
How can metals be carcinogenic? One
possible answer is based on the ability of met-
als to generate reactive oxygen species and
other reactive intermediates (Kasprzak 2002)
or react directly with DNA (Kasprzak 2002;
Kasprzak et al. 2003; O’Brien et al. 2003).
Indeed, several transition metals can generate
reactive oxygen species in biologic fluids at
physiologic pH, but this does not explain
why the relatively weak redox-active Ni(II) is
as good a carcinogen as the oxidatively very
active Cr(VI). Moreover, Cr(VI) is a better
carcinogen than Cr(III), and yet Cr(III) is
much better in DNA binding reactions than
nickel or Cr(VI) (O’Brien et al. 2003). In
addition, the highly redox-active metals iron
and copper, which also bind to DNA more
avidly than does Ni(II) (Kasprzak et al. 1986;
Trotta et al. 2002), are only weakly carcino-
genic, if at all (Desoize 2003; Theophanides
and Anastassopoulou 2002).
Another explanation may be based on the
known ability of carcinogenic metals to facili-
tate DNA damage through inhibition of DNA
repair enzymes (Hartwig et al. 2002) or bind-
ing to histones (Bal et al. 2000). In both cases,
it is assumed that the ultimate target of free
radicals or metals is DNA and that the mecha-
nisms of carcinogenesis must include genotoxic
effects. However, metals such as Ni(II) are
only weakly genotoxic/mutagenic (Biggart and
Costa 1986; Fletcher et al. 1994; Mayer et al.
1998). In addition, one major requirement for
Ni(II) carcinogenicity is prolonged action on
the target tissue (Kasprzak et al. 2003), which
is typical of tumor promoters acting through
epigenetic mechanisms, rather than tumor ini-
tiators, which are mutagenic. Therefore, Ni(II)
compounds with limited solubility and long
retention in biologic fluids are stronger car-
cinogens than are easily soluble compounds
(Kasprzak et al. 2003). So, considering the
above, it is probably time to investigate how
metals can promote carcinogenesis. Also, we
should shift our attention from DNA to pro-
teins and/or other molecules that offer a much
broader and more vulnerable target for metal
interactions. One such target is L-ascorbic acid,
or vitamin C.
The notion that ascorbate is involved in
resistance to neoplasms was introduced and
advocated by Linus Pauling (Cameron et al.
1979). This notion was based on demonstra-
tion of low ascorbate reserves in cancer
patients, and later on results of clinical trials
where survival time of cancer patients was
prolonged by ascorbate supplementation
(Cameron and Pauling 1976, 1978). It is well
known that transition metals can interact
with and destroy ascorbate (Buettner and
Jurkiewicz 1996). The role of ascorbate as an
antioxidant molecule has been appreciated for
years, but only recently ascorbate was found to
play a crucial role in hydroxylation reactions
that determine interactions and functioning of
thousands of cellular proteins. The hydroxyla-
tion is catalyzed by a variety of nonheme iron-
containing dioxygenases, including prolyl,
asparaginyl, and lysyl hydroxylases (Hewitson
et al. 2003; Myllyharju and Kivirikko 2004),
and novel DNA repairing enzymes, human
ABH2 and ABH3 proteins (Sedgwick 2004),
which requireα-ketoglutarate (2OG) as co-
factor. Most important, iron in these enzymes
is maintained in the active Fe(II) form by
ascorbate (Myllyla et al. 1984; Tschank et al.
1994). Thus, the activity of these enzymes
depends on two factors, iron and ascorbate.
Both may be targets for Ni(II) and other car-
cinogenic metals. Can this lead to carcinogen-
esis? Here, we present some of the evidence
suggesting this possibility. We discuss one
possible way—there are certainly others.
“Oxygen Sensor” Senses
Nickel
In rats, intrarenal injection of nickel subsul-
fide resulted first in a pronounced erythro-
cytosis and eventually in the development of
local tumors (Jasmin and Solymoss 1975;
Morse et al. 1977; Sunderman 1984). The
high erythrocyte counts were mediated by
increased erythropoietin (EPO) production.
Exposure of human hepatoma cells (Hep3B
or HepG2) to low oxygen atmosphere, or to
increasing amounts of Ni(II) or Co(II),
resulted in a dose-dependent enhancement of
EPO mRNA expression (Goldberg et al.
1988). These findings led to the hypothesis
that the induction of EPO by Co(II) or Ni(II)
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Environmental Medicine Reviewresulted from the substitution of the Fe(II) ion
in an “oxygen sensor” (Goldberg et al. 1988).
Reduced oxygen delivery to the kidney is the
physiologic stimulus to EPO production, and
EPO transcription is now known to be under
the control of the hypoxia-inducible factor 1
(HIF-1) (Semenza and Wang 1992). HIF-1
DNA-binding activity is similarly induced by
hypoxia or Co(II) chloride treatment, as origi-
nally described in Hep3B cells (Wang and
Semenza 1993). In fact, exposure of cells to
Co(II) was used to induce sufﬁcient HIF-1α
in cell nuclear extracts to allow biochemical
puriﬁcation (Wang and Semenza 1995).
The “oxygen sensor” hypothesis implies
that Ni(II) may interfere with Fe(II) metabo-
lism. Iron and nickel belong to the eighth
group of transition metals, with atomic num-
bers 26 and 28, respectively. Fe(II) and Ni(II)
have similar ionic radii of 0.74 Å and 0.69 Å
and similar ligand affinity (Nieboer and
Richardson 1980). This suggests that, in the-
ory, Ni(II) could be accommodated at an
enzymatic protein Fe(II)-binding site, and
substitution is possible. However, because
Ni(II) is not as redox active as Fe(II), the sub-
stitution would inactivate the enzyme. A good
example is phthalate dioxygenase that can be
poisoned by divalent metals. This enzyme
contains two iron-binding sites. A Rieske-type
[2Fe-2S] cluster serves as an electron-transfer-
ring cofactor, and a mononuclear iron site is
the putative site for substrate oxygenation,
similar to that predicted in prolyl hydroxy-
lases [prolyl hydroxylase domain (PHD)
enzymes] (Batie and Ballou 1990). Any of the
metal ions, Fe(II), Co(II), manganese(II),
Ni(II), or zinc(II), can occupy the mononu-
clear site, but only Fe(II) is competent for
effecting hydroxylation (Batie et al. 1987).
Although the substitution of metals in the
enzymes seems possible, no experimental data
indicate that this actually occurs in living cells.
Most existing data were obtained in vitro
using recombinant or biochemically isolated
proteins. In living cells, the concentration of
free transition metals is maintained at very low
levels. This must be true for both essential and
nonessential metals. Because most transition
metals are dangerous for cells, they exist inside
the cells bound to storage proteins or are
transferred to the enzymes with the help of
special metallochaperones. Such a model has
been developed for copper, and undoubtedly
similar mechanisms exist for other essential
metals (O’Halloran and Culotta 2000). Thus,
at present, the hypothesis of in situ Fe(II) sub-
stitution by Ni(II) in the cellular “oxygen sen-
sor” remains to be tested. However, besides
the iron substitution, the poisoning of “oxy-
gen sensor” may be explained in an alternative
way when the critical role of ascorbate as an
iron reductant is considered.
Depletion of intracellular ascorbate pro-
duces a phenotype observed in hypoxic cells or
in cells with mutated von Hippel-Lindau
(VHL) protein. Importantly, hypoxia is a com-
mon feature of neoplastic tumors (Hockel and
Vaupel 2001). The molecular response to
hypoxia is mediated by the HIF-1 transcription
factor that stimulates angiogenesis, changes
energy metabolism and iron homeostasis, and
promotes cell survival in the affected tissues
(Semenza 2003). Therefore, in order to survive,
tumor cells should have high HIF activity. Like
oxygen deprivation, exposure of cells to Co(II)
or Ni(II) also results in the induction of HIF-1
and production of hypoxia-like responses
(Maxwell and Salnikow 2004).
HIF-1 transcription factor is composed
of one α and one β subunit (Maxwell and
Salnikow 2004). The α subunit is the regu-
latory component of the HIF-1 complex and
is unique to the hypoxic response (Figure 1).
Under normoxic conditions, this protein is
virtually undetectable in most cells because
of hydroxylation and rapid proteasomal
destruction, but it can accumulate after expo-
sure to proteasomal inhibitors such as lacta-
cystin or MG-132 (Salceda and Caro 1997).
Accumulation of the HIF α subunit in the
presence of hypoxia or Ni(II) implies that
proteasomal degradation of the protein is
impaired by these exposures. The β subunit of
HIF-1 is constitutively expressed. In hypoxia
or after metal exposure, the α subunit dimer-
izes with a β subunit and translocates to the
nucleus. The produced HIF-1 complex binds
to the HIF response element’s initiating tran-
scription of hypoxia-inducible genes.
The β subunit is also involved in xeno-
biotic responses where HIF-1β forms a dimer
with the aryl hydrocarbon receptor (AhR).
Therefore, an alternative name for HIF-1β is
ARNT (AhR nuclear translocator) (Wang
and Semenza 1995). It is noteworthy that
although ARNT expression itself is not
directly affected by Ni(II), the expression of
AhR-dependent genes can be significantly
suppressed by Ni(II) exposure (Davidson
et al. 2003). The down-regulation of AhR-
dependent genes has an important toxicologic
implication. It may lead to a decrease in toxi-
cant removal. Because cross-talk between the
AhR-dependent pathway and HIF-dependent
pathway has been described, it is conceivable
that Ni(II) affects a major regulatory factor
upstream of both pathways. Indeed, the simi-
larity in effects of Ni(II), hypoxia, and the
inhibitor of 2OG-dependent dioxygenases
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Figure 1. Induction of hypoxia-inducible genes in hypoxia or after metal exposure. Hydroxylation of pro-
lines in HIF-α (HIF-1α and -2α) proteins by the iron-containing hydroxylases, PHD1–3, results in interaction
with VHL–ubiquitin ligase complex and proteosomal destruction (left). Hydroxylation of asparagine by FIH-
1 hydroxylase prevents HIF-α binding to a transcriptional co-activator p300. The hydroxylation reaction
requires oxygen as a substrate and ascorbate as an iron-reducing agent. Ascorbate is not produced in
cells and delivered through sodium-dependent ascorbate transporter SVCT2. In hypoxia, HIF-α proteins
cannot be hydroxylated because of low oxygen levels; in metal-exposed cells, HIF-α hydroxylation is pre-
vented by low ascorbate levels (right). Both conditions lead to the accumulation of HIF-α and formation of
HIF-1 transcription complex.(dimethyloxalylglycine) suggests that iron and
2OG-dependent dioxygenases are involved in
regulation of both pathways.
Hydroxylation-Dependent
Protein–Protein Interactions
It has been shown recently that the key 
protein–protein interactions that govern the
HIF-1 activation are regulated by oxygen
through enzymatic hydroxylation of specific
proline and asparagine residues. Hydroxylation
of proline residues 402 and 564 in the oxygen-
dependent degradation domain of HIF-1α
leads to its interaction with the VHL tumor
suppressor protein, a part of the ubiquitin–
ligase complex (Figure 1) (Ivan et al. 2001;
Jaakkola et al. 2001; Maxwell et al. 1999).
This is followed by ubiquitylation and rapid
proteosomal degradation of HIF-1α. The
structural basis for this speciﬁc interaction is
provided by the introduction of hydroxyl
group at the proline 4-position that then
facilitates hydrogen bonding with VHL’s
Ser-111 and His-115 residues. This is suffi-
cient to enable discrimination between non-
hydroxylated and hydroxylated HIF-α
(HIF-1α and -2α) proteins (Hon et al. 2002;
Ivan et al. 2001; Jaakkola et al. 2001; Masson
et al. 2001; Min et al. 2002).
Besides proline, hydroxylation of asparagine
and lysine residues was found to be important
for protein–protein interactions. Thus,
asparagine hydroxylation allows for complex
formation between HIF-1α and the CREB-
binding protein and p300 transcriptional
coactivators that in this way also become
involved in the transcriptional control of HIF-
dependent responses (Freedman et al. 2002).
The hydroxylation of proline and lysine
residues in collagen molecules serves to form
and stabilize the collagen triple helices under
physiologic conditions (Figure 2). Collagen
chains that do not contain 4-hydroxyproline
cannot fold into triple helical molecules that
are stable at body temperature (Pihlajaniemi
et al. 1991). Ascorbate plays a key role in the
trimerization step of three α-chains and/or in
the subsequent triple-helix formation of colla-
gen (Yoshikawa et al. 2001). The collagen
superfamily today includes at least 27 collagen
types with at least 42 distinct polypeptide
chains, and > 20 additional proteins with col-
lagen-like domains (Myllyharju and Kivirikko
2004). Altogether, they make up 30% of cel-
lular protein mass. In addition to collagens,
proline hydroxylation probably affects inter-
action of many more cellular proteins,
because 4-hydroxyproline residues are ubiqui-
tous in proteins with collagen-like domains
(Myllyharju and Kivirikko 2004). Among
such proteins are lung surfactant proteins A
and D, also known as collectins, or collagen-
like domain and calcium-dependent lectin
domain proteins (Crouch and Wright 2001).
Surfactant proteins A and D are found pri-
marily in the alveolar ﬂuid in lungs of mam-
malians. Their primary structure is highly
conserved among different mammalian
species. Similarly to the loss of hydroxylation
in collagen, the failure of surfactant protein
hydroxylation results in a decrease in melting
temperature of 9°C and failure of assembly of
the collagen-like domain (Garcia-Verdugo
et al. 2003).
In addition to surfactants A and D, C1q
protein, the ﬁrst component of complement,
also known as defense collagen because of its
involvement in the immunomodulation of
inflammatory and allergic responses of the
lung, contains 4-hydroxyproline in its colla-
gen domain (Lu et al. 2002). Therefore, the
loss of hydroxylation of C1q protein should
affect inﬂammatory responses in the lung.
At the tissue level, the loss of hydroxy-
prolines in the collagen-like domains of surfac-
tants A and D could impair their functions.
Surfactant inactivation and deﬁciencies have,
indeed, been associated with a variety of lung
diseases, including pneumonia, asthma, and
acute respiratory distress syndrome (Griese
1999). A similar pattern of lung diseases has
been reported for workers occupationally
exposed to Ni(II) (Kelleher et al. 2000).
Numerous data indicate that ascorbate defi-
ciency may be an underlying factor in the
pathophysiology of asthma and acute respira-
tory distress syndrome (Kelly 1998; Kongerud
et al. 2003). They are in agreement with the
hypothesis that Ni(II) may target ascorbate in
the lungs of exposed individuals.
There are at least three functional classes
of hydroxylases belonging to nonheme dioxy-
genases (Ryle and Hausinger 2002). Among
them are two long-known collagen prolyl-4-
hydroxylases (Myllyharju 2003), the more
recently identified FIH-1 (factor inhibiting
HIF), and PHD1–3, asparaginyl and prolyl
hydroxylases, responsible for HIF-α protein
hydroxylation (Epstein et al. 2001; Hewitson
et al. 2002; Lando et al. 2002; Mahon et al.
2001). The third class, characterized most
recently, includes alkyl DNA dioxygenases,
such as the Escherichia coli AlkB dioxygenase
and its two human homologues, ABH2 and
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Figure 2. Metals can affect formation of extracellular matrix (ECM) by inhibition of collagen hydroxylation
(based on Myllyharju and Kivirikko 2004). The hydroxylation of prolyl and lysyl residues in collagen peptide
is catalyzed by members of the 2OG dioxygenase family (i.e., prolyl 4-hydroxylase, prolyl 3-hydroxylase,
and lysyl hydroxylase). All enzymes require a nonhelical substrate and recognize XaaYaaGly amino acid
sequence. The reaction mechanisms of all three hydroxylases are similar, and each requires Fe(II), 2OG,
molecular O2, and ascorbate. The hydroxylation allows assembly of triple helices that are stable at body
temperature. Secreted protocollagen is assembled into collagen ﬁbrils, a major structural component of
ECM. Depletion of intracellular ascorbate by metals leads to the inhibition of collagen hydroxylation and
disorganization of ECM.ABH3, which facilitate a novel mechanism of
DNA repair (Sedgwick 2004). In the presence
of oxygen, these enzymes can specifically
hydroxylate alkyl groups on 1-methyladenine
and 3-methylcytosine (Duncan et al. 2002).
The requirement of iron for the reaction as
well as inhibition of hydroxylase activity in
crude cell extracts by iron chelators suggests
that these enzymes are iron dependent.
Inhibition by N-oxalylamino acid derivatives,
first developed for use with collagen prolyl
4-hydroxylases, further implies that these
hydroxylases are also dependent upon 2OG as
a cosubstrate (Cunliffe et al. 1992). The
source of the hydroxyl oxygen is always
(> 95%) molecular oxygen (Hayaishi and
Nozaki 1969). In the course of the hydroxyla-
tion reaction, the enzyme-bound Fe(II) splits
dioxygen into two atoms, being converted
itself to Fe(III) or Fe(IV). The exact mecha-
nism of the reaction is not known, but it is
likely that after full cycle iron is returned to
Fe(II). Any interference with the reaction, not
clearly deﬁned yet, will leave iron at a higher
oxidation state. The role of ascorbate is to
reduce iron back to Fe(II) and thus reactivate
the enzyme (de Jong et al. 1982; Myllyla et al.
1984). This scenario implies that iron deple-
tion or oxidation leads to the loss of hydroxy-
lase enzymatic activity and, again, points to
ascorbic acid as a crucial player.
Extracellular Matrix,
Ascorbate, and Tumor
Promoters
The extracellular matrix (ECM) is composed
of a great variety of molecules and includes
collagen family, elastic fibers, glycosoamino-
glycans and proteoglycans, and adhesive
glycoproteins. ECM functions to bind cells
together, to provide conditions for growth
factor–receptor interaction, and to control
growth and differentiation. It plays an impor-
tant role in maintaining structural integrity
and regulating cell polarity, migration, and
survival. The major component of the ECM is
collagen (Myllyharju and Kivirikko 2004). In
cutaneous tissues (i.e., skin), type I collagen
accounts for 80–90% of all collagenous pro-
teins in ECM (Kielty et al. 1993). Defects in
ECM can lead to developmental abnormalities
and cancer.
Neoplastic progression is associated with
speciﬁc changes in the ECM. These changes
can be observed in very early stages of tumor
development and involve, first of all, dis-
organization of the basement membrane and a
decrease in the deposition of a new collagen.
The exposure to tumor-promoting agents is
characterized by similar changes. For example,
skin treatment with the tumor-promoting
phorbol ester 12-O-tetradecanoylphorbol-13-
acetate (TPA) leads to a reduction of the colla-
gen content of the mouse dermis (Marian
1987; Marian and Mazzucco 1985). Both col-
lagen degradation and synthesis are affected by
the carcinogens, but the effect on degradation
is more pronounced (Pinto et al. 1970).
Because collagen assembly greatly depends on
ascorbate, the decrease in the ascorbate level
during spontaneous or carcinogen-induced
tumor progression could be a key factor in the
ECM disorganization (Preist 1970). Indeed, it
was shown that TPA decreases transport activ-
ity of both sodium-dependent vitamin C
transporters SVCT1 and SVCT2 (Daruwala
et al. 1999). TPA-induced depletion of intra-
cellular ascorbate can be surmounted by the
addition of ascorbate that is manifested by the
reversion of the cell-transforming activity of
TPA (Sivak and Tu 1980).
The reduced collagen expression at the
early step of carcinogenesis may cause dis-
turbed keratinocyte adhesion to the basement
membrane (Parikka et al. 2003). In in vitro
experiments, anchorage-independent growth
represents a good test for malignant transfor-
mation of cells, emphasizing an important role
of cell attachment and ECM in the carcino-
genesis process. Indeed, the transformed
phenotype of mouse fibroblasts that did not
grow in semisolid medium could be com-
pletely reverted by ascorbate exposure
(Benedict et al. 1982). Moreover, addition of
ascorbate inhibited soft agar growth of rat
osteosarcoma or human neuroblastoma cells
(Girgert et al. 1999; Sugimoto et al. 1986).
Maintenance of Ascorbate
Levels
Ascorbate is a well-known antioxidant required
by all mammalian cells for proper functioning
(Padayatty et al. 2003). Although rodents
(except for guinea pigs) produce ascorbate in
the liver, humans are unable to synthesize
ascorbate. This inability is likely to be reﬂected
in the ascorbate levels in the blood serum,
given normal consumption of ascorbate-
containing food. The comparison of ascorbate
levels in different species suggests that humans
probably have lower levels than do rodents.
Thus, a number of studies have provided val-
ues of 14.9–58.8 µM ascorbate in blood serum
for healthy volunteers receiving the recom-
mended dietary allowance of 60 mg vitamin C
daily (Levine et al. 1996). In another study,
Dawson et al. (1999) described average levels
of ascorbate of 35–40 µM. In rats, Gumuslu
et al. (2000) reported an average ascorbate level
of 63 µM in the blood serum, and in mice,
Atanasova et al. (2004) and Kuo et al. (2004)
found between 96 and 125 µM ascorbate.
These species-related differences in ascorbate
levels should be taken into consideration when
results of animal experiments are analyzed. For
example, the inhalation exposure to carcino-
genic nickel compounds resulted in increased
incidence of alveolar/bronchiolar neoplasms
and adrenal medulla neoplasms in male and
female rats but not in mice (Dunnick et al.
1995); unfortunately, in this study ascorbate
levels were not analyzed in blood or tissues of
experimental animals. Under our concept, it
is conceivable that a higher level of ascorbate
in mice protected these animals from nickel-
induced tumor development. Additionally,
the appearance of adrenal medulla neoplasms
in exposed rats can also be mediated by the
effect of Ni(II) on ascorbate levels because
adrenal medulla has the highest requirement
for ascorbate in the body (Patak et al. 2004).
Exposure to cobalt sulfate causes alveolar/
bronchiolar neoplasms both in rats and in
mice (Bucher et al. 1999), and cobalt sulfate
is more efficient in the depletion of intra-
cellular ascorbate (Salnikow et al. 2004).
Could it contribute to the effectiveness of
cobalt in animal carcinogenesis?
The maintenance of necessary intracellular
ascorbate level in humans depends on dietary
intake and subsequent distribution into cells.
Thus, the intracellular level of ascorbate
strongly depends on the ascorbate levels in the
blood or in the culture media. Ascorbic acid
and its oxidized form, dehydroascorbic acid
(DHA), both can be transported into and out
of cells (Figure 3). Glucose transporters
GLUT 1 and GLUT 3 mediate transport of
DHA (Vera et al. 1993), whereas ascorbic acid
enters cells through sodium-dependent trans-
porters SVCT1 and SVCT2 (Takanaga et al.
2004). Inside the cell, DHA is immediately
reduced to ascorbic acid, which accumulates at
higher than outside concentrations (Nualart
et al. 2003). The intracellular level of ascor-
bate is therefore regulated by its oxidation sta-
tus, uptake, and efflux. In culture medium,
the only source of ascorbate is serum. Thus,
we found the concentration of ascorbate in
Eagle minimal essential medium supple-
mented with 10% serum to be between 1 and
5 µM (Salnikow et al. 2004). At the same
time, human lung epithelial cells grown in this
medium accumulated up to 60 µM ascorbate.
Nonetheless, it is likely that cells in tissue cul-
ture do not receive adequate amounts of
ascorbate (Quievryn et al. 2002). Therefore,
the ascorbate values reported for cells in vitro
probably are lower than those existing in cells
of corresponding tissues in vivo. This may
explain rather high Km values reported for
prolyl hydroxylases. Thus, the Km values
found for PHDs were found in a range of
140–180 µM, whereas for collagen prolyl-4-
hydroxylase Km was 300 µM (Hirsila et al.
2003). The activity of DNA dioxygenases
ABH2 and ABH3 was also found to be ascor-
bate dependent; however, the Km values for
the enzymes were not measured (Duncan
et al. 2002). The maintenance of intracellular
level of ascorbate therefore is critical for the
activity of speciﬁc hydroxylases.
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Transition Metals
The intra- and extracellular levels of ascorbate
can be greatly affected by the interaction with
metals (Figure 3). In the absence of molecular
oxygen, the reactions of ascorbic acid with cer-
tain transition metal ions, especially Fe(III),
Cu(II), mercury(II) [Hg(II)], or Cr(VI), result
in their reduction and oxidation of ascorbic
acid to DHA, for example, 2Fe(III) + ascorbic
acid → 2Fe(II) + DHA + 2H+ (Tsao 1997).
However, in the presence of oxygen or other
oxidants, such as hydrogen peroxide or lipid
peroxides, these metals act predominantly as
catalysts in a chain of partially radical reac-
tions (Khan and Martell 1967). The metal
catalyst cycles between its original and lower
valency state. These reactions include the for-
mation of a binary complex between the
metal and mono-deprotonated ascorbic acid
molecule, and dioxygen coordination by the
bound metal. Once ascorbate is oxidized, the
metal is dissociated because it cannot be
bound to DHA.
Other metals, such as Zn(II), Ni(II),
Co(II), or lead(II) [Pb(II)], which do not
accept electrons at neutral pH, can neither
oxidize ascorbic acid by themselves nor serve
as catalysts for oxidation with molecular oxy-
gen (Fridman et al. 1979; Khan and Martell
1967). However, this is only true for simple
aqueous solutions in which only binary metal–
ascorbate complexes can be formed. In tissue
ﬂuids and cell culture media, the situation is
radically different owing to the presence of a
wide variety of natural metal complexing
agents (chelators), such as amino acids, pep-
tides, proteins, nucleotides, and glutathione,
which may bind and profoundly affect the
redox potential of these metals (Holmes and
Williams 2000) or their dioxygen coordina-
tion capacity (Boca 1983; Van Horn et al.
2003) and thus make them catalytically active
toward ascorbate oxidation. Most important,
such ligands may form ternary complexes with
the metal and ascorbic acid (Fridman et al.
1983). Among natural chelators, histidine and
histidine-containing peptides, especially those
having the N-terminal XaaYaaHis motif (e.g.,
albumin), play the major role in biologic bind-
ing of transition metals such as Cu(II), Ni(II),
or Co(II) (Harford and Sarkar 1995). The
ascorbic acid in these complexes was found to
be oxidized by ambient oxygen much faster
than was ascorbic acid alone (Puplikova and
Savich 1969). Besides histidine, other amino
acids, including glycine, alanine, serine,
phenylalanine, and glutamic acid, have been
found to form ternary complexes with Ni(II)
and ascorbic acid, with stability of those with
histidine and glutamic acid being highest
(Fridman et al. 1979, 1981, 1983).
Transition metal chelation by compo-
nents of biologic fluids other than ascorbic
acid may also facilitate the oxidative destruc-
tion of the latter through more indirect
mechanisms, for example, those involving
Fenton-like chemistry with metabolic H2O2
and generation of reactive oxygen and other
radical species from lipid peroxides. These are
avidly scavenged by the ascorbate anion, thus
lowering its tissue levels (Buettner and
Jurkiewicz 1996). The best examples of this
effect would include facilitation by Ni(II), a
non-Fenton metal, reactivity with O2 or
H2O2 through chelation with polyglycyl,
polyalanyl, or histidine-containing oligo-
peptides (Bossu et al. 1978; Datta et al. 1993).
In cells, the oxidation of ascorbate to
DHA is readily reversible owing to specific
enzymatic systems, including DHA reductase,
glutaredoxins, and protein disulﬁde isomerase,
and depends on glutathione or other thiols as
electron donors (Tsao 1997). However, unlike
ascorbic acid, DHA undergoes relatively fast
(t1/2 ~ 2–15 min at pH 7) spontaneous
hydrolysis to a product, 2,3-diketogulonic
acid, which cannot be regenerated. In addi-
tion, DHA and 2,3-diketogulonic acid may
also be further oxidized by molecular oxygen,
H2O2, and some metal oxyanions (perman-
ganate, chromate) to products such as threonic
acid, oxalic acid, and various smaller products
(e.g., carbon dioxide) that cannot be reverted
back to ascorbic acid (Deutsch 1998).
There also is a possibility that metals can
form complexes with derivatives of ascorbic
acid, such as ascorbate-2-sulfate, 2-O-β-
glucuronide, and 2-O-α-glucoside that have
been found in mammalian cells (Davey et al.
2000), and ascorbate-6-phosphate, which has
been found in bacteria (Zhang et al. 2003) but
has not yet been detected in mammalian cells.
The Key Role of Ascorbate in
Nickel Toxicity and
Carcinogenesis
The effect of Ni(II) compounds on cells is
complex and most likely involves modulation
of many metabolic pathways. Recently, we
found that Ni(II) exposure greatly depleted
intracellular ascorbate, which results in the
activation of the HIF-1 transcription factor
and up-regulation of hypoxia-inducible genes
(Salnikow et al. 2004). The addition of ascor-
bate to the media caused an increase in intra-
cellular ascorbate and reversed both metal-
induced stabilization of HIF-1α and HIF-1–
dependent gene transcription. Recently, the
important role of ascorbate in down-regulation
of HIF-1α level in tumor cell lines has been
demonstrated (Knowles et al. 2003).
The depletion of intracellular ascorbate, as
the initial step of Ni(II) toxicity, has profound
effects on cellular and tissue metabolism. It
shifts cellular homeostasis toward a more
transformed phenotype. Here, we are consid-
ering three major modifications in cellular
metabolism due to the depletion of intra-
cellular ascorbate by Ni(II): a) induction of
hypoxia-like stress, b) impairment of assembly
of proteins with collagen-like domains, and
c) inactivation of ascorbate-dependent DNA
repair enzymes.
Exposure of human or rodent cells to Ni(II)
stabilizes HIF-1α and induces HIF-1 transcrip-
tional activity, followed by the induction of gly-
colytic enzymes and glucose transporters
(Salnikow et al. 1999, 2003). The up-regula-
tion of the glycolytic pathway may be beneﬁcial
for cell survival, and if Ni(II) exposure is pro-
longed, it may select cells that maintain a high
glycolytic rate and thereby acquire a phenotype
similar to cancer cells, as described by Warburg
(1956). In addition, other hypoxia-inducible
genes, including BCL-2 binding protein Nip3,
EGLN1, hypoxia-inducible gene 1 (HIG1),
prolyl-4 hydroxylase, and cyclin G2, and
growth factors, such as platelet-derived growth
factor BB and vascular endothelial growth fac-
tor (VEGF), are up-regulated by Ni(II) in an
HIF-dependent manner (Kuwabara et al. 1995;
Namiki et al. 1995; Salnikow et al. 2003;
Steinbrech et al. 2000).
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Figure 3. Metal-induced ascorbate depletion.
Numerous iron-containing hydroxylases that are
involved in collagen, carnitine, catecholamine, and
tyrosine metabolism all require ascorbic acid (AA) to
maintain iron in reduced form. In tissue culture
media, the level of AA is 1–5 µM, and it is dependent
on the source of serum. In cells AA is accumulated
> 10- to 50-fold compared with the media levels
because of uptake of both DHA, via Glut 1, and AA,
via sodium-dependent ascorbate transporter SVCT2.
Once oxidized to DHA, ascorbate can be reduced
inside the cell, or be released from cells to the
media in the form of DHA. In the media, DHA can be
reduced to AA and transported back to cells. Ni(II)
and Co(II), after binding to ligands, are capable of
catalyzing ascorbate oxidation to DHA both in the
media and inside the cell. In the presence of met-
als, DHA is not stable and can be hydrolyzed to
diketogulonate (DKG) and other products. Arrows
show the preferential pathway of metabolic conver-
sion of ascorbate. Both Ni(II) and Co(II) could also
block ascorbate transport into cells. The loss of
intracellular ascorbate results in accumulation of
oxidized iron [increased ratio Fe(III):Fe(II)] in the
enzymes, which causes their inactivation.Although the benefit of up-regulation of
some hypoxia-inducible genes for cell survival
and transformation is not understood, the up-
regulation of others is clearly beneﬁcial. Thus,
up-regulation of cyclin G2 ceases cell prolifera-
tion, allowing conservation of energy (Horne
et al. 1997). The up-regulation of growth fac-
tors has an antiapoptotic effect and helps to
sustain cell growth by both autocrine and
paracrine regulatory mechanisms (Tran et al.
2002). In the long term, VEGF as a major
tumor angiogenesis and vascular permeability
factor can support cell survival and growth via
enhanced blood supply. Angiogenesis can be
further stimulated by the suppression of anti-
angiogenic factors such as thrombospondin I.
Both Ni(II) and hypoxia suppress throm-
bospondin I expression (Laderoute et al. 2000;
Salnikow et al. 1994). The importance of HIF
activation and expression of HIF target genes
for evolution of a more malignant phenotype
was shown in an animal model system (Elson
et al. 2000). Additionally, immunostaining
studies using monoclonal antibodies against
the HIF α-subunits demonstrated increased
HIF-1α expression in about 53% of malignant
tumors, including colon, breast, gastric, lung,
ovarian, pancreatic, prostate, and renal cell car-
cinomas, melanomas, and glioblastomas as
compared with the respective normal tissues
(Zhong et al. 1998). In another study,
increased protein levels of both HIF-1α and
HIF-2α were detected in about 54% of tumors
screened (Talks et al. 2000).
Similarly to hypoxia, Ni(II) exposure up-
regulates HIF-1 and transactivates HIF-1–
dependent genes that are critical for invasion
and metastasis that can be facilitated by the
impairment of ECM. It is expected that colla-
gen assembly will be affected even before HIF
activation because the Km for ascorbate of col-
lagen hydroxylase is twice as high as the Km
for HIF hydroxylases. Nothing, however, is
known about the effect of Ni(II) on collagen
hydroxylation and assembly.
The destruction of ECM selects for cells
that can proliferate without attachment, which
can be tested as the loss of anchorage depen-
dence. Indeed, the loss of anchorage depen-
dence is well documented in human and
hamster nickel-transformed cells (Biedermann
and Landolph 1987; Conway and Costa
1989; Costa et al. 1979; Lin and Costa 1994).
Almost all nickel-transformed clones are also
capable of producing tumors in nude mice
(Costa et al. 1979). Recently, we have shown
that the expression of HIF-1α is required for
the induction of soft agar growth by Ni(II)
(Salnikow et al. 2003). Under the concept of
our hypothesis, it is conceivable that the dis-
ruption of ECM and activation of hypoxia-
like stress inside cells will provide perfect
conditions for selection of cells with neoplastic
phenotype. Additionally, inactivation of DNA
dioxygenases may introduce mutations pre-
serving selected phenotypes. Nickel is a weak
mutagen; therefore, one assumption would be
that the Km for ascorbate for these enzymes is
rather low. Alternatively, DNA dioxygenases
repair N1 alkylated adenines, which are not
major mutagenic lesions.
If the hypothesis discussed here is true,
one may predict that supplementation with
ascorbate should alleviate carcinogenic effects
of Ni(II). Although the direct data are not
available and further investigations are needed
to demonstrate protective effect of ascorbate in
Ni(II) carcinogenesis, many data demonstrate
preventive effects of ascorbate supplementa-
tion against Ni(II) toxicity: prevention of oral
Ni(II) toxicity in weanling rats (Chatterjee
et al. 1979); suppression of nickel-induced
lipid peroxidation in human platelets and pla-
centa (Chen and Lin 1998, 2001) and in
mouse and rat liver (Chen et al. 1998a,
1998b; Das et al. 2001); decrease in nickel-
induced cytokine production and elevated
serum levels of hepatic transaminases in rats
(Chen et al. 1998a); reversion of nickel-caused
decrease in hepatic glutathione level and
superoxide dismutase, catalase, and gluta-
thione peroxidase activities in rats (Das et al.
2001); alleviation of clastogenic effects of
Ni(II) in murine bone marrow (Dhir et al.
1991); and prevention of DNA damage and
increase of viability of human lymphocytes
cultured with Ni(II) (Osipova et al. 1998).
Osipova et al. (1998) proposed using ascor-
bate as an antimutagenic agent on nickel-
exposed workers. It is noteworthy that in
contrast to reports of aggravation by ascorbate
of nickel-mediated in vitro toxicity (Kasprzak
and Hernandez 1989), consistent with the
known generation of reactive oxygen species in
metal–ascorbate solutions (Buettner and
Jurkiewicz 1996), no such effects have been
thus far observed in nickel-exposed and ascor-
bate-supplemented cells and tissues.
Conclusion
Recent investigations clearly show that the
cellular ascorbate is greatly depleted by expo-
sure to Ni(II) compounds, which results in
the inhibition of prolyl hydroxylase activity
and activation of HIF-1α and expression of
hypoxia-inducible genes. The addition of
ascorbate reverses these as well as a variety of
other toxic effects of Ni(II) in cultured cells
and animals. All this indicates that ascorbate
may be the major target in nickel-induced
toxicity and carcinogenesis. However, the
hypothesis of the key role of ascorbate in Ni(II)
carcinogenesis awaits further testing because
the critical experiments are yet to be per-
formed. Among them, most important is test-
ing nickel carcinogenicity in mice or rats with
mutations in L-gulono-γ-lactone oxidase that
make them unable to synthesize ascorbate.
Monitoring levels of ascorbate during cell
transformation in vitro or during tumorigenesis
in vivo is another important task. The elucida-
tion of the role of ascorbate depletion in the
development of nickel-induced neoplasms
could serve as a basis for prevention and treat-
ment of Ni(II) and, perhaps, also other metal-
induced human cancer. Bearing this in mind,
we quote Cameron et al. (1979), from a histor-
ical paper published 25 years ago: “We agree
and believe it to be essential that extensive
studies of ascorbic acid in cancer be made
without delay.”
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